37 related articles for article (PubMed ID: 10330687)
1. The effect of peroxisome proliferators on mitochondrial bioenergetics.
Zhou S; Wallace KB
Toxicol Sci; 1999 Mar; 48(1):82-9. PubMed ID: 10330687
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine (PF9601N) on mitochondrial permeability transition.
Battaglia V; Sanz E; Salvi M; Unzeta M; Toninello A
Cell Mol Life Sci; 2006 Jun; 63(12):1440-8. PubMed ID: 16767355
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I.
Brunmair B; Lest A; Staniek K; Gras F; Scharf N; Roden M; Nohl H; Waldhäusl W; Fürnsinn C
J Pharmacol Exp Ther; 2004 Oct; 311(1):109-14. PubMed ID: 15166256
[TBL] [Abstract][Full Text] [Related]
4. Leveraging Cell Painting Images to Expand the Applicability Domain and Actively Improve Deep Learning Quantitative Structure-Activity Relationship Models.
Herman D; Kańduła MM; Freitas LGA; van Dongen C; Le Van T; Mesens N; Jaensch S; Gustin E; Micholt L; Lardeau CH; Varsakelis C; Reumers J; Zoffmann S; Will Y; Peeters PJ; Ceulemans H
Chem Res Toxicol; 2023 Jul; 36(7):1028-1036. PubMed ID: 37327474
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome Proliferator-Activated Receptors and Caloric Restriction-Common Pathways Affecting Metabolism, Health, and Longevity.
Duszka K; Gregor A; Guillou H; König J; Wahli W
Cells; 2020 Jul; 9(7):. PubMed ID: 32708786
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin and Gemfibrozil Modulate Differently Hepatic and Colonic Mitochondrial Respiration in Tissue Homogenates from Healthy Rats.
Herminghaus A; Laser E; Schulz J; Truse R; Vollmer C; Bauer I; Picker O
Cells; 2019 Aug; 8(9):. PubMed ID: 31461874
[TBL] [Abstract][Full Text] [Related]
7. PPARs modulate cardiac metabolism and mitochondrial function in diabetes.
Lee TW; Bai KJ; Lee TI; Chao TF; Kao YH; Chen YJ
J Biomed Sci; 2017 Jan; 24(1):5. PubMed ID: 28069019
[TBL] [Abstract][Full Text] [Related]
8. Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?
Morel J; Singer M
Intensive Care Med Exp; 2014 Dec; 2(1):9. PubMed ID: 26266909
[TBL] [Abstract][Full Text] [Related]
9. NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells.
Han D; Wei W; Chen X; Zhang Y; Wang Y; Zhang J; Wang X; Yu T; Hu Q; Liu N; You Y
Oncotarget; 2015 Sep; 6(28):26119-28. PubMed ID: 26172294
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.
Grabacka M; Waligorski P; Zapata A; Blake DA; Wyczechowska D; Wilk A; Rutkowska M; Vashistha H; Ayyala R; Ponnusamy T; John VT; Culicchia F; Wisniewska-Becker A; Reiss K
J Physiol Pharmacol; 2015 Apr; 66(2):233-47. PubMed ID: 25903954
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships for perfluoroalkane-induced in vitro interference with rat liver mitochondrial respiration.
Wallace KB; Kissling GE; Melnick RL; Blystone CR
Toxicol Lett; 2013 Oct; 222(3):257-64. PubMed ID: 23954199
[TBL] [Abstract][Full Text] [Related]
12. A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.
Guyton KZ; Chiu WA; Bateson TF; Jinot J; Scott CS; Brown RC; Caldwell JC
Environ Health Perspect; 2009 Nov; 117(11):1664-72. PubMed ID: 20049115
[TBL] [Abstract][Full Text] [Related]
13. Myopathy with statin-fibrate combination therapy: clinical considerations.
Jacobson TA
Nat Rev Endocrinol; 2009 Sep; 5(9):507-18. PubMed ID: 19636324
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with the peroxisome proliferator-activated receptor alpha agonist Wy-14,643 attenuates myocardial respiratory capacity and contractile function.
Zungu M; Young ME; Stanley WC; Essop MF
Mol Cell Biochem; 2009 Oct; 330(1-2):55-62. PubMed ID: 19360380
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
Scatena R; Bottoni P; Giardina B
PPAR Res; 2008; 2008():256251. PubMed ID: 18645611
[TBL] [Abstract][Full Text] [Related]
16. PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle.
Constantin D; Constantin-Teodosiu D; Layfield R; Tsintzas K; Bennett AJ; Greenhaff PL
J Physiol; 2007 Aug; 583(Pt 1):381-90. PubMed ID: 17540700
[TBL] [Abstract][Full Text] [Related]
17. Key issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity.
Keshava N; Caldwell JC
Environ Health Perspect; 2006 Sep; 114(9):1464-70. PubMed ID: 16966106
[TBL] [Abstract][Full Text] [Related]
18. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.
Rusyn I; Peters JM; Cunningham ML
Crit Rev Toxicol; 2006 May; 36(5):459-79. PubMed ID: 16954067
[TBL] [Abstract][Full Text] [Related]
19. Reduction of palmitate-induced cardiac apoptosis by fenofibrate.
Kong JY; Rabkin SW
Mol Cell Biochem; 2004 Mar; 258(1-2):1-13. PubMed ID: 15030165
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
